Pathology & Laboratory Medicine

You are here

Newly Awarded Grants

National Cancer Institute (NIH)

Research Grant
Title: Cell Cycle Reprogramming for Therapeutic Targeting of BTK in Lymphoma
Principal Investigator: Dr. Selina Chen-Kiang, PhD
Period of Support: 08/05/14-07/31/19
Total Direct Costs: $1,037,500

National Cancer Institute (NIH)

Research Grant
Title: Cell cycle sensitization to PI3K therapy in lymphoma
Principal Investigator: Dr. Selina Chen-Kiang, PhD
Period of Support: 11/01/2014-10/31/2017
Total Direct Costs: $540,054

Goldhirsh-Yellin Foundation

Research Grant
Title: Molecular Characterization of Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract
Principal Investigator: Thomas J. Fahey III
Co-Investigator: Yi-Chieh Nancy Du, PhD
Period of Support: 02/01/14-01/31/17
Total Direct Costs: $197,088

Fondation Leducq

Research Grant
Title: Sphingosine 1-phosphate in neurovascular biology and disease (SphingoNet)
Principal Investigator: Timothy Hla, PhD
Period of Support: 10/01/14-09/30/19
Total Direct Costs: $1,658,100

Seed Grants for Collaborations Between Cornell University-Ithaca and Weill Cornell Medical College of Cornell University

Research Grant
Title: Redox-linked mechanisms of HuR protein regulation in angiogenesis
Principal Investigator: Timothy Hla, PhD
Period of Support: 07/01/2014-06/30/2015
Total Direct Costs: $23,746

National Institute on Aging (NIH)

Research Grant
Title: The Mechanisms Underlying How Oxidative Stress Influences Neural Stem Cell Fate
Principal Investigator: Jihye Paik, PhD
Period of Support: 09/15/14-05/31/19
Total Direct Costs: $1,025,000

Prostate Cancer Foundation

Janssen Special Challenge Award
Title: Targeting and mechanistic insights underlying N-Myc driven Neuroendocrine Prostate Cancer
Principal Investigator: David Rickman, PhD (Co-PI Dr. Mark A. Rubin)
Period of Support: 04/04/14-04/04/16
Total Direct Costs: $500,000

National Cancer Institute (NIH)

Research Grant
Title: Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resistance in Castration-Resistant Prostate Cancer
Principal Investigator: David Rickman, PhD
Period of Support: 04/11/14-02/28/19
Total Direct Costs: $1,265,135

National Cancer Institute (NIH)

Research Grant
Title: Precision Medicine Approach to Prostate Cancer Active Surveillance
Principal Investigator: Dr. Mark A. Rubin, MD
Period of Support: 08/01/2014-07/31/2019
Total Direct Costs: $2,754,075  

Weill Cornell Medicine Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-2700 Fax: (212) 746-8624